Team:USTC CHINA/Project/ProjectDetails/Background
From 2013.igem.org
(Difference between revisions)
Line 74: | Line 74: | ||
<p>When this idea first stroke us, it seemed amazing that our dream is so naïve and unpractical. Above all, how can we make antigen get through the skin barrier? We refer to various transdermal methods, like Iontophoresis, Sonophoresis, Microneedle. They require special equipment and deal damage to skin. Our idea remained unrealistic until we find Transdermal peptide 1.<p> | <p>When this idea first stroke us, it seemed amazing that our dream is so naïve and unpractical. Above all, how can we make antigen get through the skin barrier? We refer to various transdermal methods, like Iontophoresis, Sonophoresis, Microneedle. They require special equipment and deal damage to skin. Our idea remained unrealistic until we find Transdermal peptide 1.<p> | ||
<p>TD-1 is an eleven amino acid peptide, which can greatly facilitate macromolecule transdermal delivery through intact skin. This was first discovered by professor Wen Longping in our university and the results were published on Nature biotechnology.<p> | <p>TD-1 is an eleven amino acid peptide, which can greatly facilitate macromolecule transdermal delivery through intact skin. This was first discovered by professor Wen Longping in our university and the results were published on Nature biotechnology.<p> | ||
- | + | TD1序列<br> | |
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
插入TD1的nature文章标题<br> | 插入TD1的nature文章标题<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
<h3>2. the Principle of TD1:<h3> | <h3>2. the Principle of TD1:<h3> | ||
<p>The biggest challenge of penetrating the skin is epidermis of skin barrier. Traditional transdermal methods have to break the epidermis, though it maybe painless, the injury still have the potential of infection. On the contrary, TD1 is painless and harmless to skin, it could open the skin channels shortly, so not only molecules but also filobactivirus could penetrate the skin and go into the blood circulation system.<p> | <p>The biggest challenge of penetrating the skin is epidermis of skin barrier. Traditional transdermal methods have to break the epidermis, though it maybe painless, the injury still have the potential of infection. On the contrary, TD1 is painless and harmless to skin, it could open the skin channels shortly, so not only molecules but also filobactivirus could penetrate the skin and go into the blood circulation system.<p> | ||
插入噬菌体图片<br> | 插入噬菌体图片<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
插入皮肤图片<br> | 插入皮肤图片<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
插入旻少的eGFP过皮图<br> | 插入旻少的eGFP过皮图<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
<h3>3. Many Advantages of TD1:<P> | <h3>3. Many Advantages of TD1:<P> | ||
插入其他方式的图片<br> | 插入其他方式的图片<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
插入TD1和其他的透皮方式的对比<br> | 插入TD1和其他的透皮方式的对比<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
插入微针注射后的图片<br> | 插入微针注射后的图片<br> | ||
+ | <img src="https://static.igem.org/mediawiki/2013/a/a7/Nature.png" width="580" height="500" /> | ||
</div> | </div> |
Revision as of 07:03, 27 September 2013